NTLA
Priority
FDA PDUFA Target Action Date · Intellia Therapeutics, Inc.
Wednesday, March 10, 2027
116 days away
Drug Information
- Drug Name
- Priority (CT.gov)
- Application Type
- Priority Review
Filing Details
- Company
- Intellia Therapeutics, Inc.
- Stock Ticker
- NTLA
- SEC CIK
- 0001652130
- Source
- SEC filing →
What is a PDUFA Date?
A PDUFA (Prescription Drug User Fee Act) date is the FDA's target deadline to complete review of a drug application. The FDA aims to make an approval decision by this date.
- Standard Review: 10 months from filing acceptance
- Priority Review: 6 months from filing acceptance
- Possible Outcomes: Approval, Complete Response Letter (CRL), or extension
Track All FDA Decisions
View all upcoming PDUFA dates and AdCom meetings on our FDA Calendar.
View FDA Calendar →Data sourced from SEC EDGAR filings. Last updated: 2026-11-05. Report an issue